期刊文献+

miR-214对HepG2细胞增殖及细胞周期影响 被引量:2

Effect of miR-214 on proliferation and cell cycle in hepatocellular carcinoma cells
原文传递
导出
摘要 目的探讨miR-214对Hep G2细胞增殖及细胞周期的影响。方法 Realtime-PCR法检测肝癌细胞株SMMC-7721、Hep G2、SK-Hep-1、Huh 7、Hep3B及正常肝细胞L-02中miR-214表达量,并利用脂质体转染miR-214NC及miR-214 mimics,采用Realtime-PCR法检测转染效果;采用MTT法、流式细胞术分别检测miR-214对肝癌细胞活力、凋亡及细胞周期影响;蛋白印迹(WB)检测miR-214对肝癌细胞中细胞周期蛋白D1(cyclin D1),细胞周期蛋白依赖性激酶4(CDK4),生存素(survivin)及增值细胞核抗原(PCNA)表达影响。结果 miR-214在肝癌细胞SMMC-7721、SK-Hep-1、Huh 7、Hep3B、Hep G2中表达量[分别为(1.25±0.10)、(1.43±0.10)、(0.95±0.09)、(0.98±0.01)、(0.82±0.08)]明显低于正常肝细胞L-02(2.52±0.23),其中Hep G2中miR-214表达量最低。miR-214 mimics组Hep G2细胞中miR-214表达量(2.38±0.23)明显高于miR-214 NC组(0.83±0.08),miR-214mimics组Hep G2细胞活力(0.37±0.03)明显低于miR-214 NC组(0.78±0.07);与miR-214 NC组比较,miR-214mimics组Hep G2细胞凋亡率明显升高,细胞周期阻滞于G1期,cyclin D1、CDK4、survivin及PCNA表达量下调,差异均有统计学意义(P<0.01)。结论上调miR-214表达可抑制肝癌细胞增殖,其机制可能与调控细胞周期相关蛋白表达水平有关。 Objective To explore inhibitive effect of miR-214 on proliferation and cell cycle in hepatocellular carci- noma cells. Methods The expression of rniR-214 in hepatoceUular carcinoma cells of SMMC-7721 ,HepG2,SK-Hep-1, Huh 7, and Hep3B and normal liver cell L-02 was detected with realtime-PCR. Hepatocellular carcinoma cells were trans- fected with miR-214 NC and miR-214 mimics by liposome and the outcome of the transfection was determined with real-tirne-PCR. The cell viability, cell apoptosis and cell cycle was assessed with (3-( 4,5-dimethyl-2-thiazolyl)-2,5-diphen- yl-2-H-tetrazolium bromide (MTT) assay and flow cytometry, respectively. The expression of cyclin D1, cyclin-depend- ent protein kinases (CDK4) ,survivin,and proliferating cell nuclear antigen (PCNA) were detected with Western blot. Results The expression of miR-214 in the cells of SMMC-7721 ( 1.25±0. 10 ), SK-Hep-1 (1. 43 ±0. 10 ), Huh 7 (0. 95±0. 09) ,Hep3B (0. 98 ±0. 0) ,and HepG2 (0. 82 ±0. 08) were all lower than that in L-02 cells (2. 52±0. 23) and the expression of miR-214 was the lowest in HepG2 cells. The expression of miR-214 in rniR-214 mimics HepG2 cells (2. 38±0. 23 ) was higher than that in miR-214 NC HepG2 cells ( 0. 83±0. 08 ). The cell viability of rniR-214 mimics HepG2 cells (0. 37 ±0. 03) was lower than that of rniR-214 NC cells (0. 78±0. 07). Compared with those of the rniR-214 NC HepG2 cells ,the cell apoptotic rate was increased;cell cycle was arrested at G1 ;and expressions of cyclin D1, CDK4, survivin, and PCNA were down-regulated in miR-214 mimics HepG2 cells, with significant differences be- tween the two groups ( P 〈0. 01 for all). Conclusion miR-214 mimics inhibits HepG2 cell proliferation;the mechanism of the inhibitive effect may be related to the expression of cell cycle regulation related protein.
出处 《中国公共卫生》 CAS CSCD 北大核心 2017年第4期614-617,共4页 Chinese Journal of Public Health
关键词 miR-214 肝癌细胞 增殖 细胞周期 miR-214 hepatocellular carcinoma proliferation cell cycle
  • 相关文献

参考文献6

二级参考文献118

  • 1Luigi Rossi,Federica Zoratto,Anselmo Papa,Francesca Iodice,Marina Minozzi,Luigi Frati,Silverio Tomao.Current approach in the treatment of hepatocellular carcinoma[J].World Journal of Gastrointestinal Oncology,2010,2(9):348-359. 被引量:11
  • 2段琼红,张金荣,卢祖洵,韩胜红,聂绍发.大肠癌中survivin表达及相关性[J].中国公共卫生,2006,22(12):1421-1423. 被引量:5
  • 3Johnson ME, Howerth EW. Survivin: a bifunctional inhibitor of apoptosis protein[ J]. Vet Pathol,2004 ,41 ( 6 ) :599 - 607.
  • 4Montorsi M,Maggioni M, Falleni M, et al. Survivin gene expression in chronic liver disease and hepatoceUular carcinoma [ J ]. Hepatogastroenterology ,2007,54 (79) : 2040 - 2044.
  • 5Yang X,Xiong G,Chen X,et al. Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma[J]. J Cancer Res Clin Oncol,2009, 135 (10) : 1341 - 1349.
  • 6Yang X,Xiong G,Chen X,et al. Survivin expression in esophageal cancer:correlation with 1153 mutations and promoter polymorphism [ J ]. Dis Esophagus, 2009,22 ( 3 ) : 223 - 230.
  • 7Jang JS, Kim KM, Kang KH, et al. Polymorphisms in the survivin gene and the risk of lung cancer[J]. Lung Cancer,2008,60( 1 ) : 31 -39.
  • 8Huang Q, Fu YX, Boerwinkle E. Comparison of strategies for selecting single nucleotide polymorphisms for case/control association studies[J].Hum Genet ,2003,113 ( 3 ) :253 - 257.
  • 9施渺筱,宋宝安,杨松.卵巢癌筛查标记物研究进展[J].中国公共卫生,2007,23(9):1150-1152. 被引量:4
  • 10HUNTER T, COOPER J A. Protein-tyrosine kinases [J]. Annu Rev Biochem, 1985(54): 897-930.

共引文献9

同被引文献14

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部